​

Funding Round

Series A - RetiSpec

Series A - RetiSpec

Investment Firm

Overview

RetiSpec is a medical imaging startup developing an eye scanner for early detection of Alzheimer’s Disease pathology.

Announced Date

Jul 26, 2024

Closed on Date

Jul 26, 2024

Funding Type

Series A

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

iGan Partners

iGan Partners

iGan Partners is a convertible_note and debt and early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

8

Investor Name
Participant InvestorOntario Brain Institute
Participant InvestorGentex Corporation
Participant InvestorUniversity of Minnesota
Participant InvestoriGan Partners
Participant InvestorEli Lilly

Round Details and Background

RetiSpec raised $9975264 on 2024-07-26 in Series A

RetiSpec is a medical imaging startup developing an eye scanner for early detection of Alzheimer’s Disease pathology.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 16, 2019
Grant - RetiSpec
1-500.0K
Jan 01, 2018
Pre Seed Round - RetiSpec
1-undefined
Apr 13, 2023
Grant - RetiSpec
1-undefined
Jul 26, 2024
Series A - RetiSpec
9-10.0M

Recent Activity

News

Aug 28, 2024

RetiSpec Closes $10 Million in Series A Funding

News

Jul 29, 2024

FinSMEs - RetiSpec Closes $10M USD in Series A Funding

News

Jul 29, 2024

Private Capital Journal - RetiSpec secures US $10M Series A

News

Jul 26, 2024

BetaKit - RetiSpec secures $13.8 million Series A to detect Alzheimer’s early through retinal imaging

News

Jul 26, 2024

linkedin.com - RetiSpec’s Post

News

Jul 26, 2024

PR Newswire - RetiSpec Closes $10M USD to Advance Commercialization of its AI-Driven Eye Test for Detection of Alzheimer's Disease